tradingkey.logo
tradingkey.logo
Search

Autonomix Medical Inc

AMIX
Add to Watchlist
6.850USD
-0.010-0.15%
Close 08-14 16:00ETQuotes delayed by 15 min
6.65MMarket Cap
LossP/E TTM

More Details of Autonomix Medical Inc Company

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Inc Profile

Ticker SymbolAMIX
Company nameAutonomix Medical Inc
IPO dateJan 29, 2024
CEOHauser (Bradley)
Number of employees8
Security typeOrdinary Share
Fiscal year-endJan 29
Address21 Waterway Ave, Suite 300
CityTHE WOODLANDS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code77380
Phone18322777816
Websitehttps://autonomix.com/
Ticker SymbolAMIX
IPO dateJan 29, 2024
CEOHauser (Bradley)

Company Executives of Autonomix Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
179.00
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
179.00
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%

FAQs

Who are the top five shareholders of Autonomix Medical Inc?

The top five shareholders of Autonomix Medical Inc are: Mr. Landy Toth

How many institutions hold shares of Autonomix Medical Inc (AMIX)?

As of 2026Q1, 42 institutions hold shares of Autonomix Medical Inc, with a combined market value of approximately 319.97K, accounting for 2.80% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -276558.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.